APA
Niazi A., Ahmed M. & Dow University of Health Science. (2022). Comparison of empagliflozin and vildagliptin for efficacy and safety in Type 2 diabetes mellitus in Pakistani population. Karachi: .
Chicago
Niazi Asima, Ahmed Mansoor and Dow University of Health Science. 2022. Comparison of empagliflozin and vildagliptin for efficacy and safety in Type 2 diabetes mellitus in Pakistani population. Karachi: .
Harvard
Niazi A., Ahmed M. and Dow University of Health Science. (2022). Comparison of empagliflozin and vildagliptin for efficacy and safety in Type 2 diabetes mellitus in Pakistani population. Karachi: .
MLA
Niazi Asima, Ahmed Mansoor and Dow University of Health Science. Comparison of empagliflozin and vildagliptin for efficacy and safety in Type 2 diabetes mellitus in Pakistani population. Karachi: . 2022.
Text